Barely Significant
← all excerpts

Outcomes of relapse after teclistamab therapy in multiple myeloma.

Blood Cancer J · 2025 · PMC12586613 · PMID 41188250

Europe PMCDOI
1
hedged sentence
0.1300
closest p · 2.6× alpha
0.1300
boldest claim

The sentences

a nonsignificant trendP = 0.13not close (p > 0.1)
There was a nonsignificant trend toward higher ORR in patients receiving CART or TCE-based salvage therapy compared to others (55% vs. 32%; P = 0.13).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.